Powered 500 · 2026POWEREDS. 208 of 500
Saklayen built Cellino Biotech around a bet that laser-based cell engineering paired with machine learning can crack the unsolved economics of manufacturing autologous cell therapies — one of regenerative medicine's most stubborn production problems — at a scale that makes personalized treatments clinically viable.
Nabiha Saklayen co-founded Cellino Biotech, a Massachusetts regenerative-medicine company developing autologous cell-therapy manufacturing platforms that combine laser-based cell engineering with machine learning.
Under her leadership Cellino has raised significant venture funding and advanced toward clinical-stage personalized cell therapies. She was named a 2025 EY Entrepreneur of the Year New England Award winner for the company's work on a scalable approach to one-off biological products.
Interview · In Pipeline
Sponsored placement
An invitation, extended to Powered readers.
Drive the Continental GT S.
Request a test driveBentley T&Cs apply
